ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Obituaries: Sylvan Green, Donald Gleason

January 23, 2009

NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category

April 26, 1974

Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes

June 11, 1993

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010